Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says
Revolution Medicines (RVMD) should post "strong launch numbers" for pancreatic cancer drug Rasonque
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
